Compounds > tibolone
Page last updated: 2024-08-16

tibolone and Venous Thrombosis

tibolone has been researched along with Venous Thrombosis in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dahm, AEA; Eilertsen, AL; Høibraaten, E; Lofthus, CM; Mowinckel, MC; Sandset, PM1
Jespersen, J; Nilas, L; Sidelmann, JJ; Skouby, SO1
Ayhan, A; Demirol, A; Gurgan, T; Guven, S; Guvendag Guven, ES; Kirazli, S1
Eilertsen, AL; Hemker, HC; Liestøl, S; Mowinckel, MC; Sandset, PM1
Alexandrou, AP; Bastounis, E; Bramis, J; Christodoulakos, GE; Creatsas, GC; Dalamanga, A; Keramaris, NC; Lambrinoudaki, IV1

Trials

4 trial(s) available for tibolone and Venous Thrombosis

ArticleYear
Relationship between sex hormone binding globulin and blood coagulation in women on postmenopausal hormone treatment.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2019, Volume: 30, Issue:1

    Topics: Activated Protein C Resistance; Blood Coagulation; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Sex Hormone-Binding Globulin; Venous Thrombosis

2019
Comparison of the effects of tibolone and estrogen therapy on hemostasis in surgical menopause: a randomized, double-blind, placebo-controlled study.
    Fertility and sterility, 2007, Volume: 87, Issue:4

    Topics: Antithrombin III; Blood Coagulation Factors; Double-Blind Method; Estrogens, Conjugated (USP); Female; Hemostasis; Humans; Hysterectomy; Lipoprotein(a); Menopause; Middle Aged; Norpregnenes; Partial Thromboplastin Time; Prospective Studies; Salpingostomy; Venous Thrombosis

2007
Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system.
    Thrombosis and haemostasis, 2007, Volume: 97, Issue:6

    Topics: Activated Protein C Resistance; Administration, Oral; Blood Coagulation; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Protein C; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tablets; Thromboembolism; Treatment Outcome; Venous Thrombosis

2007
The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
    Climacteric : the journal of the International Menopause Society, 2007, Volume: 10, Issue:5

    Topics: Analysis of Variance; Blood Coagulation; Blood Coagulation Factors; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Estradiol Congeners; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fibrinolysis; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Thromboembolism; Venous Thrombosis

2007

Other Studies

1 other study(ies) available for tibolone and Venous Thrombosis

ArticleYear
A comparative study of the effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on blood coagulability.
    Human reproduction (Oxford, England), 2007, Volume: 22, Issue:4

    Topics: Aged; Animals; Blood Coagulation; Estrogen Receptor Modulators; Estrogens, Conjugated (USP); Female; Hemostasis; Horses; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Thromboembolism; Venous Thrombosis

2007